The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

Hacke, Werner; W. Albers, Gregory; Al‐Rawi, Yasir; Bogousslavsky, Julien; Dávalos, Antonio; Eliasziw, Michael; Fischer, Michael; J. Furlan, Anthony; Kaste, Markku; R. Lees, Kennedy; Soehngen, Mariola; Warach, Steven

doi:10.1161/01.str.0000149938.08731.2c

Public

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

Published in Stroke • Nov 30, 2004

Authors:

Werner Hacke

Gregory W. Albers

Yasir Al‐Rawi

Abstract

BACKGROUND AND PURPOSE: Most acute ischemic stroke patients arrive after the 3-hour time window for recombinant tissue plasminogen activator (rtPA) administration. The Desmoteplase In Acute Ischemic Stroke trial (DIAS) was a dose-finding randomized trial designed to evaluate the safety and efficacy ...

Subject

Medicine

Modified Rankin Scale

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!